BPC-157: Handling, Storage, and Reconstitution Guide

This guide covers laboratory handling, storage, and reconstitution of BPC-157 as a lyophilized research peptide. Every step below is framed as laboratory best practice for in-vitro and animal-model preparation, not as human-use instruction.

BPC-157 Handling and Storage Fundamentals

BPC-157 ships as a solid, white lyophilized powder in a sealed glass vial. Store the lyophilized material at or below 25 degrees Celsius, sealed, and protected from heat, light, and moisture. For extended storage, keep it lyophilized and refrigerated or frozen. The reported stability of BPC-157 is an advantage, but consistent storage still protects integrity across a study.

Puritide supplies BPC-157 in 5 mg, 10 mg, and 20 mg vials, so working-stock concentration is set by the diluent volume you choose for the labeled mass.

The reported stability of BPC-157 is a handling convenience, but it does not remove the need for disciplined storage. Even a robust peptide degrades faster under repeated thermal cycling and moisture exposure, so the same cold-chain and low-humidity practices that protect more fragile materials still apply and still protect data quality.

Confirm the Peptide Form First

BPC-157 exists as a free-acid peptide and as an acetate salt, with different molecular weights (about 1419.5 g/mol free acid versus 1479.6 g/mol acetate) and different CAS numbers (137525-51-0 versus 216441-37-1). Because peptide products are commonly supplied as the acetate salt, confirm the form on the certificate of analysis before calculating concentrations. Getting this right is essential for the quantitative work described in the BPC-157 research applications.

Reconstitution for In-Vitro Preparation

Reconstitute lyophilized BPC-157 with bacteriostatic water or another solvent appropriate to the assay. Add the diluent slowly down the inner wall of the vial rather than directly onto the powder, and let the peptide dissolve gently. Swirl; do not vortex aggressively or shake, which can shear the peptide and cause foaming.

• Introduce diluent against the vial wall, not onto the pellet.
• Allow gentle dissolution; avoid vigorous agitation.
• Inspect for complete dissolution before use.
• Compute concentration from labeled mass, diluent volume, and peptide form.

Aliquoting to Limit Freeze-Thaw

Divide reconstituted BPC-157 into single-use aliquots so each experiment draws from a vial thawed only once. Label each with compound name, concentration, date, lot number, and peptide form. Minimizing freeze-thaw cycles preserves the consistent exposure that repair and cytoprotection assays depend on, and mirrors the practice in the TB-500 handling guide.

Cold-Chain and Working-Solution Storage

Store reconstituted aliquots frozen for longer holds, and keep short-term working solutions cold and protected from light. Maintain consistent conditions throughout the study and monitor storage records as part of quality assurance. Documenting time-at-temperature supports reproducibility and audit readiness.

COA and Lot Verification

Each BPC-157 batch ships with a third-party-verified certificate of analysis documenting purity (HPLC / reverse-phase chromatography), mass-spectrometry identity confirmation, and lot, testing date, and method details. Verify the COA against the vial label, confirm the peptide form, and retain the document with your batch records. Sample COAs can be requested ahead of purchase.

PPE and Institutional Compliance

Handle BPC-157 as an investigational material. Follow institutional SOPs, chemical hygiene plans, and approved protocols; wear a lab coat, gloves, and eye protection; and use engineering controls where required. All handling should be performed by qualified personnel in controlled environments. The BPC-157 mechanism of action and the BPC-157 product page provide the specification context for verification.

At intake, match the vial to its recorded synonyms and confirm the expected white lyophilized appearance, then verify the salt form so concentration math is correct from the outset. Given how widely BPC-157 is used, a consistent intake-verification habit is one of the simplest ways to keep results comparable across studies and across the several vial sizes offered.

Documentation Across Multiple Vial Sizes

Because BPC-157 is offered in several vial sizes, a shared documentation habit prevents mix-ups. Each preparation record should capture the vial size, the peptide form, the diluent volume, and the resulting concentration, so that stocks made from a 5 mg vial are never confused with those from a 20 mg vial. This is straightforward but easy to overlook when several preparations are in play at once.

Retaining the certificate of analysis with each record closes the loop. If a later experiment produces an unexpected result, the documentation lets investigators check whether the material, its form, or its concentration could explain the difference, rather than leaving the preparation as an untracked variable.

Consistent handling is ultimately a reproducibility measure. A BPC-157 preparation that is verified against its certificate of analysis, reconstituted gently, aliquoted to limit freeze-thaw, stored under stable cold-chain conditions, and fully documented gives every downstream experiment the same reliable starting material. That consistency is what allows independent laboratories to compare results and build on one another's work with confidence. When a study later proves difficult to reproduce, a complete handling record is often what lets investigators distinguish a genuine biological difference from a preparation artifact, which is why the effort invested in disciplined BPC-157 handling repays itself throughout a project.

For research use only. These handling notes describe laboratory practice for BPC-157 as a research material supplied by Puritide Research. BPC-157 is not approved for human or veterinary use, and nothing here constitutes medical or administration guidance.